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Abstract: An enantioselective Michael addition– four-atom
ring expansion cascade reaction involving cyclobutanones
activated by a N-aryl secondary amide group and ortho-amino
nitrostyrenes has been developed for the preparation of
functionalized eight-membered benzolactams using bifunc-
tional aminocatalysts. Taking advantage of the secondary
amide activating group, the eight-membered cyclic products
could be further rearranged into their six-membered isomers
having a glutarimide core under base catalysis conditions
without erosion of optical purity, featuring an overall ring
expansion– ring contraction strategy.
Benzazocinones, that are eight-membered cyclic lactams
fused to a benzene ring, are privileged scaffolds that can be
found in various synthetic and natural products endowed with
important biological activities (Figure 1).[1, 2] However, the
construction of medium-sized rings by organic synthesis is
notoriously difficult because of inherent unfavorable
enthalpic and entropic factors, as well as undesired trans-
annular interactions.[1] Although steady progresses have been
made for the synthesis of medium-sized heterocycles, the
direct synthesis of azocane derivatives remains a largely
unsolved issue,[3] especially when considering catalytic enan-
tioselective approaches. There has been only a handful of
examples of enantioselective syntheses reported on this
poorly-charted area of chemical space (Scheme 1a). The
Rovis group described a rhodium(I)-catalyzed [4+2+2]
cycloaddition using a chiral phosphoramidite ligand,[4] while
Dong and co-workers developed a rhodium(I)-catalyzed
redox neutral annulative hydroacylation employing a chiral
diphosphine ligand.[5] Lately, two organocatalytic approaches
were reported relying on Lewis base catalysis: Lu, Ullah, and
co-workers proposed a (4+4) annulation based on allenes
activation with a chiral phosphine catalyst to afford azo-
cines,[6] and the group of Romo used the reactivity of
catalytically generated a,b-unsaturated acyl ammonium salts
with a chiral tertiary amine catalyst in (5+3) annulations.[7]
Over the last two decades, organocatalytic cascade reactions
have established as a general and sustainable strategy to
rapidly access highly functionalized, structurally diverse and
complex molecules free from metal residues.[8] Nevertheless,
most of the established organocascades focus on the prepa-
ration of energetically favorable five- and six-membered
rings. Otherwise, ring expansion strategies provide an appeal-
ing way to prepare medium-sized rings from readily available
small rings.[9] Herein, we propose a direct enantioselective
organocatalytic synthesis of benzazocinones based on
a Michael addition– four-atom ring expansion cascade from
activated cyclobutanones and ortho-amino nitrostyrene deriv-
atives using bifunctional aminocatalysts (Scheme 1b). The
base-catalyzed ring contraction of benzazocinone products
into their six-membered ring isomers having a glutarimide
core with retention of optical purity is also demonstrated.
Based on our previous work,[10] the cyclobutanone 1a
activated by aN-aryl secondary amide group at the a position
and the ortho-amino nitrostyrene derivative 2a were selected
as the prototypical substrates to test our hypothesis with the
bifunctional aminocatalystOC1[11] in toluene,meta-xylene, or
dichloroethane. To our delight, the expected benzazocinone
product 3a (dr= 4:1 to 5:1) was identified as the largely major
product with 70% yield in toluene and meta-xylene and 51%
yield in dichloroethane, with excellent enantioselectivities
(Scheme 2). No Michael adduct or hemiketal intermediate
was detected in the crude reaction mixtures. With the
intention to optimize these results, organocatalysts OC2–
OC12 were screened for the same reaction.[12] The results are
listed in Scheme 2. It was found that cinchonine and
quinidine-derived squaramides OC1 and OC2 are optimum
for the synthesis of benzazocinone 3a in terms of practic-
Figure 1. Selected examples of benzazocinones in natural products
and bioactive molecules.
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ability, yield, and enantioselectivity. Catalyst OC3, a hydro-
genated version of catalyst OC2, afforded the product in
significantly reduced efficiency and enantioselectivity, while
catalyst OC4, a sterically hindered version of catalyst OC2,
gave a comparable result to catalyst OC1. Catalysts OC5 and
OC6 having a N-3,5-bis(trifluoromethyl)phenyl and a N-tert-
butyl, respectively, in place of the N-3,5-bis(trifluoromethyl)-
benzyl group found inOC2 gave only modest yields of 3awith
complete loss of the enantioselectivity. Catalyst OC7 derived
from quinine is the pseudo-enantiomer of catalyst OC2, and
as such it delivered 3a in similar yield but opposite and still
excellent enantioselectivity. With catalyst OC8, a diastereo-
mer of OC2, the reaction afforded only 26% yield of 3a as
a nearly racemic product, indicating a strong mismatch effect
in this case. The replacement of the squaramide double
hydrogen bond donor moiety by a thiourea inOC10 or a urea
inOC11, as well as the use of the so-called Takemoto catalyst
OC9 having a different chiral backbone, gave the product 3a
in only moderate yields and enantioselectivities. Finally,
catalyst OC12 having a missing NˇH bond promoted the
reaction at a very slow rate (< 10% conversion after 4 days).
Notably, the diastereoselectivity of the reaction is not much
affected by the nature of the catalyst, the product 3a being
systematically obtained as an about 5:1 mixture of the trans
and cis diastereomers, respectively.
With optimized reaction conditions in hand, we examined
the scope of this original transformation. The results are
summarized in Scheme 3. Initially, a series of cyclobutanones
1 bearing different N-aryl secondary amide activating groups
were examined. All of them reacted smoothly with the ortho-
amino nitrostyrene 2a to afford the desired benzazocinone
products 3b–j and ent-3k in fair to good yields along with
high to excellent enantioselectivities. The absolute config-
uration of product 3b was unambiguously determined to be
(5S,6R) by X-ray diffraction techniques (see the Supporting
Information),[13] which is consistent with previous results.[10] In
line with previous studies on organocatalytic Michael addi-
tions with secondary b-ketoamides,[10,14] substrates bearing
a R1 electron-withdrawing substituent systematically afforded
better enantioselectivities, which was attributed to the higher
acidity of the secondary amide NˇH proton in these cases
resulting in more compact and better-defined transition states
in the Michael addition step. As a scope limiting issue, the
analog of 1 having a N-tert-butyl group in place of the N-aryl
substituent did not react with nitrostyrene 2a using catalyst
OC1, while catalyst OC9 promoted only the corresponding
Michael addition at a slow rate without evidence for any
fragmentation.[10,15] The secondary amide N-aryl substituent
in 1 seems essential for the overall cascade to proceed,
probably a consequence of the higher acidity, and thus higher
electron-withdrawing character, of secondary N-aryl amides
compared to N-alkyl amides.[14a] Modifications of the ortho-
amino nitrostyrene substrate were also possible as illustrated
by the introduction of an alkyl or a halogen substituent on the
phenyl ring in 3 l and 3m, respectively, and by variations of the
carbamate protecting group in 3n–p, while maintaining high
levels of enantioselectivity. If all reactions proceeded with
high to excellent enantioselectivities, their diastereoselectiv-
ities were found to be influenced by steric factors. For
Scheme 1. Enantioselective approaches to azocane derivatives.
Scheme 2. Organocatalysts screening. Yields for isolated pure prod-
ucts. The dr values were determined by 1H NMR analysis of the crude
reaction mixtures, and ee were determined for the pure products by
HPLC analyses on chiral stationary phases. [a] Reaction performed in
meta-xylene. [b] Reaction performed in 1,2-dichloroethane.
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example, products 3b and 3j only differ by the position of the
para- ormeta-NO2 substituent on the secondary amide phenyl
ring and were obtained as 9:1 and 15:1 mixtures of diaste-
reomers, respectively. Also, 3 l is an ortho-methylated analog
of 3a on the fused benzo ring, which strongly influenced the
diastereoselectivity (5:1 dr for 3a vs. > 25:1 dr for 3 l). DFT
calculations indicated a stabilization energy of about
10 kJmolˇ1 for the trans diastereomers of 3a and 3 l relative
to their cis isomers (see the Supporting Information). Some
degree of thermodynamic control of the diastereoselectivity
could be evidenced: 3k (the enantiomer of ent-3k) was
prepared using catalystOC1 (70% yield, 10:1 dr, 83% ee) and
chromatographic techniques allowed us to obtain a sample of
3k enriched in the minor diastereomer with dr= 2:1. This
material was placed back under the reaction conditions with
5 mol%OC1 in toluene. Periodical monitoring of the mixture
by 1H NMR analysis of aliquots showed a slow conversion of
the minor diastereomer into the major one with dr= 3.6:1
after 20 h and dr= 7:1 after 50 h without significant decom-
position.
To further demonstrate the potential of this enantiose-
lective synthesis of benzazocinones, we examined their base-
catalyzed ring contraction into the corresponding glutari-
mides exploiting the reactivity of the pendant N-aryl secon-
dary amide group (Scheme 4). Notably, chiral glutarimide
moieties are found in biologically active natural and synthetic
products including marketed drugs,[16] but enantioselective
methods for their synthesis remain scarce.[7,17] A screening of
archetypal Brønsted and Lewis bases with substrate 3b
(Table S1 in the Supporting Information) allowed identifying
DBU as a competent catalyst for the desired transformation,
which after optimization afforded the glutarimide 4b in good
yield without significant erosion of optical purity but some
epimerization at the imide enolizable position. Similarly, the
benzazocinones 3e, 3eh, 3ei and ent-3k reacted with DBU to
afford the corresponding glutarimides 4e, 4h, 4 i, and ent-4k.
Mechanistically, this transformation may proceed by a ther-
modynamically-controlled transannular ring-rearrangement
involving the Brønsted base properties of the catalyst. A pure
sample of the minor diastereomer epi-ent-4k was obtained by
semi-preparative HPLC techniques and submitted back to the
reaction conditions, which afforded a 3:1 mixture of ent-4k
Scheme 3. Substrates scope. Reactions were performed on a 0.1–
1.0 mmol scale. Yields for isolated pure products. The dr values were
determined by 1H NMR analysis of the crude reaction mixtures, and ee
were determined for the pure products by HPLC analyses on chiral
stationary phases.
Scheme 4. Ring contraction of benzazocinones into glutarimides. The
major diastereomers are depicted, dr values were determined by
1H NMR analysis of the crude reaction mixtures, ee are reported for
the major and minor diastereomers, respectively, and were determined
for the pure products by HPLC analyses on chiral stationary phases.
DBU=1,8-Diazabicyclo[5.4.0]undec-7-ene.
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and epi-ent-4k. This experiment probed some degree of
thermodynamic control in the diastereoselectivity of the ring
rearrangement reaction, probably owing to a DBU-catalyzed
epimerization at the imide enolizable position. DFT calcu-
lations allowed a tentative assignment of the relative config-
uration in ent-4k with a stabilization energy of 7.5 kJmolˇ1
for the (R,S) diastereomers depicted in Scheme 4 (see the
Supporting Information for details). It is remarkable that
glutarimides 4b, 4e, 4h, 4 i, and ent-4k overall derive from the
corresponding activated cyclobutanones 1 by an enantiose-
lective ring expansion– ring contraction approach.[18]
In summary, an enantioselective synthesis of benzazoci-
nones has been elaborated based on aMichael addition– four-
atom ring expansion cascade from activated cyclobutanones
and ortho-amino nitrostyrenes using bifunctional aminocata-
lysts. This newly developed approach allows a straightforward
access to a class of molecules usually difficult to synthesize in
optically active form, from readily available starting materi-
als, and under mild conditions. The benzazocinone products
can be further converted into functionalized glutarimide
derivatives without loss of the enantiomeric purity by a base-
catalyzed ring contraction.
Supporting information for this article is given via a link at
the end of the document. It contains detailed experimental
procedures, full characterization data, details of the computa-
tional studies and single crystal X-ray diffraction analysis data
for 3b.
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